Joel Cohn, MD
Interventional Cardiology · Lansing, MINPI 1922006873
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 221 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by Boston Scientific at 33.7% of the total. Reporting peaked in 2023 at $1,558 and has fallen 54.1% since, to $714 in 2025. That places this record below the midpoint for interventional cardiology clinicians in MI, where the typical reported total is $6,857.
Across 221 payments — averaging $31.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Abbott$722
- Shockwave Medical, Inc$626
- Johnson & Johnson$319
- Boehringer Ingelheim$304
- Amgen$285
- plus $2K from 28 others
Across 23 payments — averaging $5013.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$102K
- Bayer$10K
- Biotronik Inc.$2K
What the payments were for
- Food & beverage$6,93699%
- Education$541%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 61 | $2,352 |
| Abbott | 9 | $722 |
| Shockwave Medical, Inc | 13 | $626 |
| Johnson & Johnson | 22 | $319 |
| Boehringer Ingelheim | 13 | $304 |
| Amgen | 11 | $285 |
| E.r. Squibb & Sons, L.L.C. | 13 | $243 |
| Abiomed | 3 | $232 |
| Novartis | 16 | $232 |
| Penumbra, Inc. | 2 | $199 |
| Medtronic(2 entities) | 8 | $156 |
| Pfizer | 8 | $132 |
| Cardiovascular Systems Inc. | 1 | $120 |
| Actelion Pharmaceuticals US, Inc. | 4 | $110 |
| Philips North America LLC | 1 | $107 |
| Cardiva Medical, Inc. | 2 | $93 |
| Biotronik Inc. | 5 | $83 |
| Bayer | 5 | $80 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $76 |
| AstraZeneca(2 entities) | 5 | $75 |
| Inspire Medical Systems, Inc. | 1 | $69 |
| Inari Medical, Inc. | 1 | $54 |
| Bridgebio Pharma, Inc. | 2 | $47 |
| Atricure, Inc. | 1 | $44 |
| Sanofi-aventis U.S. LLC | 2 | $34 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $28 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Edwards Lifesciences | 1 | $24 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $24 |
| Heartflow, Inc. | 1 | $23 |
| Teleflex LLC | 1 | $22 |
| Siemens Medical Solutions USA, Inc. | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $17 |
| Livanova USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$244
- AVVIGO Guidance System$150
- MitraClip$134
- STINGRAY$133
- Allure Quadra RF CRT Pacemaker$133
- Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripher$125
- Peripheral Orbital Atherectomy System$120
- Coronary Orbital Atherectomy System$120
- Impella$116
- WATCHMAN Access System$113
- Indigo$108
- (6574) Coronary Other$107
- Repatha$103
- QUADRA ALLURE MP$102
- Confirm Rx$100
How this compares
$6,990 in reported general payments places this provider in the 50th percentile of 187 interventional cardiology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 58 | $68,754 |
| EntrestoSacubitril/Valsartan | 12 | $17,661 |
| XareltoRivaroxaban | 15 | $17,198 |
| Repatha SureclickEvolocumab | 21 | $12,248 |
| Rosuvastatin Calcium | 135 | $3,129 |
| Ranolazine ErRanolazine | 13 | $1,997 |
| ClopidogrelClopidogrel Bisulfate | 100 | $1,988 |
| Dofetilide | 14 | $1,684 |
| Nitroglycerin | 19 | $1,647 |
| Ezetimibe | 42 | $1,331 |
| Metoprolol Succinate | 73 | $1,093 |
| Carvedilol | 70 | $1,002 |
| Losartan Potassium | 64 | $951 |
| Cilostazol | 22 | $846 |
| Bumetanide | 16 | $823 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $132 | $68,75458 claims |
| NovartisEntresto | $232 | $17,66112 claims |
| Johnson & JohnsonXarelto | $319 | $17,19815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 187 interventional cardiology providers in Michigan.
Other interventional cardiology in Lansing
- Mohammed QintarLansing$35K
- Adnan KassierLansing$28K
- Maria MarkarianLansing$22K
- Nam ChoLansing$19K
- Amir KakiDetroit$1.8M
- Tamam MohamadDetroit$960K
- Paul GrossmanAnn Arbor$630K
- Jason RicciPetoskey$594K
- Tim FischellKalamazoo$468K
- Mir BasirDetroit$442K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.